EXACT Therapeutics AS (FRA:56F)

Germany flag Germany · Delayed Price · Currency is EUR
0.0950
-0.0025 (-2.56%)
Last updated: Apr 24, 2026, 8:03 AM CET
Market Cap8.21M -50.6%
Revenue (ttm)4.99K
Net Income-7.35M
EPS-0.12
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0950
Previous Close0.0975
Day's Range0.0950 - 0.0950
52-Week Range0.0685 - 0.2260
Betan/a
RSI42.60
Earnings DateApr 8, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 11
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 56F

Financial Performance

Financial numbers in NOK Financial Statements